Variation in risk indicators of cardiovascular disease during the menstrual cycle: An investigation of within-subject variations in glutathione peroxidase, haemostatic variables, lipids and lipoproteins in healthy young women
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 56 (3) , 241-249
- https://doi.org/10.3109/00365519609088613
Abstract
Larsen LF, Andersen HR, Hansen AB, Andersen O. Variation in risk indicators of cardiovascular disease during the menstrual cycle: an investigation of within-subject variations in glutathione peroxidase, haemostatic variables, lipids and lipoproteins in healthy young women. Scand J Clin Lab Invest 1996; 56: 241–249. Variations in erythrocyte glutathione peroxidase activity, serum concentrations of lipids and lipoproteins and in blood coagulation and fibrinolysis during the menstrual cycle were studied in healthy young women. Blood samples were drawn twice a week for 9 weeks. A group of males was used for estimation of the influence on the results of factors which were not related to the menstrual cycle. Variations during the menstrual cycle were demonstrated in several of the factors analysed. The activity of glutathione peroxidase was lowest at ovulation. The clotting activity of factor II + VII+X and the concentration of fibrinogen were lowest during mid-cycle, and the number of platelets increased in the follicular phase (days 5–9). Statistically significant variations in the fibrinolytic factors analysed (tissue plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI)) were not observed during the menstrual cycle. The serum concentrations of cholesterol and LDL cholesterol were significantly higher at the start of the menstrual cycle (days 3–8) than later in the cycle (days 19–24). The concentration of HDL cholesterol was lowest in the late luteal phase (days 23–28).Keywords
This publication has 27 references indexed in Scilit:
- Lipid and hormonal profile of Panamanian women during the menstrual cycleInternational Journal of Gynecology & Obstetrics, 1992
- Disparate serum lipid changes between normotensive and hypertensive women during the menstrual cycleThe American Journal of Cardiology, 1992
- Oxidative status and oral contraceptive. Its relevance to platelet abnormalities and cardiovascular riskFree Radical Biology & Medicine, 1991
- Sex hormones, lipoproteins, and cardiovascular riskAtherosclerosis, 1991
- Metabolic changes during the normal menstrual cycle: A longitudinal studyAmerican Journal of Obstetrics and Gynecology, 1990
- Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroidAmerican Journal of Obstetrics and Gynecology, 1990
- Lipid Metabolism and Coagulation During the Normal Menstrual CycleHormone and Metabolic Research, 1989
- Studies On Blood Viscosity During The Menstrual Cycle And In The Postmenopausal Period In Healthy WomenActa Obstetricia et Gynecologica Scandinavica, 1989
- Changes in lipoprotein composition during the menstrual cycleMetabolism, 1979
- Variation in the Individual Subject of Some Parameters in Blood Coagulation and FibrinolysisScandinavian Journal of Haematology, 1969